News Focus
News Focus
Followers 46
Posts 6184
Boards Moderated 0
Alias Born 11/15/2013

Re: kund post# 483892

Wednesday, 02/26/2025 9:31:33 PM

Wednesday, February 26, 2025 9:31:33 PM

Post# of 517129
Blarcamesine remains safe and effective while AD is still an unmet need. The EMA encouraged Anavex to go the pathway of full approval. Tutes are now steady increasing. The days of knocking on the CEO are getting shorter. I also added today..All and all seems like very good odds for EMA approval.
Bullish
Bullish

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News